{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T14:55:03Z","timestamp":1788360903924,"version":"build-2803163510"},"reference-count":181,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007194","name":"Wenzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007194","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.phrs.2024.107280","type":"journal-article","created":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T16:00:46Z","timestamp":1719072046000},"page":"107280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["RNA epigenetic modifications in digestive tract cancers: Friends or foes"],"prefix":"10.1016","volume":"206","author":[{"given":"Zekai","family":"Nian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lele","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinya","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiliu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyang","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyv","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruonan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yicheng","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanlu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gangqiang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.phrs.2024.107280_bib1","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1053\/j.gastro.2012.03.008","article-title":"Circulating microRNA in digestive tract cancers","volume":"142","author":"Ichikawa","year":"2012","journal-title":"Gastroenterology"},{"issue":"7529","key":"10.1016\/j.phrs.2024.107280_bib2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/516S1a","article-title":"Liver cancer","volume":"516","author":"Gravitz","year":"2014","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.phrs.2024.107280_bib3","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1053\/j.gastro.2020.09.058","article-title":"Epigenetic alterations in the gastrointestinal tract: current and emerging use for biomarkers of cancer","volume":"160","author":"Grady","year":"2021","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.phrs.2024.107280_bib4","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1200\/JCO.22.02331","article-title":"Immunotherapy and targeted therapy for advanced gastroesophageal cancer: ASCO guideline","volume":"41","author":"Shah","year":"2023","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.phrs.2024.107280_bib5","first-page":"372","article-title":"Clinical management of metastatic colorectal cancer in the era of precision medicine, CA: a cancer","volume":"72","author":"Ciardiello","year":"2022","journal-title":"J. Clin."},{"issue":"7","key":"10.1016\/j.phrs.2024.107280_bib6","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and treatment of metastatic colorectal cancer: a review","volume":"325","author":"Biller","year":"2021","journal-title":"Jama"},{"issue":"2","key":"10.1016\/j.phrs.2024.107280_bib7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1053\/j.gastro.2019.07.055","article-title":"Epidemiology and mechanisms of the increasing incidence of colon and rectal cancers in young adults","volume":"158","author":"Stoffel","year":"2020","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.phrs.2024.107280_bib8","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1053\/j.gastro.2019.01.259","article-title":"Early detection of pancreatic cancer: opportunities and challenges","volume":"156","author":"Singhi","year":"2019","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.phrs.2024.107280_bib9","first-page":"620","article-title":"Biomarkers and molecular diagnosis of gastrointestinal and pancreatic neoplasms, Nature reviews","volume":"7","author":"Melton","year":"2010","journal-title":"Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.phrs.2024.107280_bib10","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/clinchem\/hvz004","article-title":"Level of N6-methyladenosine in peripheral blood RNA: a novel predictive biomarker for gastric cancer","volume":"66","author":"Ge","year":"2020","journal-title":"Clin. Chem."},{"issue":"2","key":"10.1016\/j.phrs.2024.107280_bib11","first-page":"111","article-title":"Epigenetics of colorectal cancer: biomarker and therapeutic potential, Nature reviews","volume":"17","author":"Jung","year":"2020","journal-title":"Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.phrs.2024.107280_bib12","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1101\/gad.1787609","article-title":"An operational definition of epigenetics","volume":"23","author":"Berger","year":"2009","journal-title":"Genes Dev."},{"issue":"6","key":"10.1016\/j.phrs.2024.107280_bib13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrg.2016.47","article-title":"RNA modifications: what have we learned and where are we headed?","volume":"17","author":"Frye","year":"2016","journal-title":"Nat. Rev. Genet."},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrm.2016.132","article-title":"Post-transcriptional gene regulation by mRNA modifications","volume":"18","author":"Zhao","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.phrs.2024.107280_bib15","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ccell.2020.02.004","article-title":"m(6)A modification in coding and Non-coding RNAs: roles and therapeutic implications in cancer","volume":"37","author":"Huang","year":"2020","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.phrs.2024.107280_bib16","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","article-title":"Reading, writing and erasing mRNA methylation","volume":"20","author":"Zaccara","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.tig.2022.10.004","article-title":"Genetic and epigenetic defects of the RNA modification machinery in cancer","volume":"39","author":"Orsolic","year":"2023","journal-title":"Trends Genet.\u00a0TIG"},{"issue":"6","key":"10.1016\/j.phrs.2024.107280_bib18","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41568-020-0253-2","article-title":"Role of RNA modifications in cancer","volume":"20","author":"Barbieri","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.phrs.2024.107280_bib19","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41380-023-02339-x","article-title":"Advances in brain epitranscriptomics research and translational opportunities","volume":"29","author":"Zhang","year":"2024","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib20","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12943-019-1099-7","article-title":"N(6)-methyladenosine (m(6)A) RNA modification in gastrointestinal tract cancers: roles, mechanisms, and applications","volume":"18","author":"Hu","year":"2019","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.phrs.2024.107280_bib21","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41419-023-05736-w","article-title":"Aberrant RNA m(6)A modification in gastrointestinal malignancies: versatile regulators of cancer hallmarks and novel therapeutic opportunities","volume":"14","author":"Shen","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2024.107280_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215815","article-title":"N6-methyladenosine modification and metabolic reprogramming of digestive system malignancies","volume":"544","author":"Cai","year":"2022","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13045-020-00895-1","article-title":"Emerging role of RNA methyltransferase METTL3 in gastrointestinal cancer","volume":"13","author":"Wang","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12943-022-01634-5","article-title":"The role, mechanism, and application of RNA methyltransferase METTL14 in gastrointestinal cancer","volume":"21","author":"Shi","year":"2022","journal-title":"Mol. Cancer"},{"issue":"14","key":"10.1016\/j.phrs.2024.107280_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14143489","article-title":"N(6)-methyladenosine RNA-binding protein YTHDF1 in gastrointestinal cancers: function, molecular mechanism and clinical implication","volume":"14","author":"Chen","year":"2022","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.phrs.2024.107280_bib26","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1093\/cvr\/cvab160","article-title":"mRNA modifications in cardiovascular biology and disease: with a focus on m6A modification","volume":"118","author":"Kumari","year":"2022","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.phrs.2024.107280_bib27","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/CIRCULATIONAHA.118.036146","article-title":"The N(6)-methyladenosine mRNA methylase METTL3 controls cardiac homeostasis and hypertrophy","volume":"139","author":"Dorn","year":"2019","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.phrs.2024.107280_bib28","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.201800233","article-title":"m(6)A-mRNA methylation regulates cardiac gene expression and cellular growth","volume":"2","author":"Kmietczyk","year":"2019","journal-title":"Life Sci. Alliance"},{"issue":"7","key":"10.1016\/j.phrs.2024.107280_bib29","first-page":"2484","article-title":"Myocardial knockdown of mRNA-stabilizing protein HuR attenuates post-MI inflammatory response and left ventricular dysfunction in IL-10-null mice","volume":"24","author":"Krishnamurthy","year":"2010","journal-title":"FASEB J.\u00a0Off. Publ. Fed. Am. Soc. Exp. Biol."},{"issue":"11","key":"10.1016\/j.phrs.2024.107280_bib30","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/nm.4416","article-title":"The N(6)-methyladenosine (m(6)A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells","volume":"23","author":"Vu","year":"2017","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.phrs.2024.107280_bib31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.stem.2017.11.016","article-title":"METTL14 inhibits hematopoietic stem\/progenitor differentiation and promotes leukemogenesis via mRNA m(6)A modification","volume":"22","author":"Weng","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.phrs.2024.107280_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101641","article-title":"The crucial mechanism and therapeutic implication of RNA methylation in bone pathophysiology","volume":"79","author":"Yang","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.phrs.2024.107280_bib33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev-immunol-070119-115104","article-title":"Interaction between the microbiota, epithelia, and immune cells in the intestine","volume":"38","author":"Kayama","year":"2020","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib34","doi-asserted-by":"crossref","first-page":"7038","DOI":"10.1038\/s41467-022-34808-2","article-title":"N6-methyladenosine modification governs liver glycogenesis by stabilizing the glycogen synthase 2 mRNA","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib35","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1038\/s41467-022-32169-4","article-title":"Mettl3-mediated mRNA m(6)A modification controls postnatal liver development by modulating the transcription factor Hnf4a","volume":"13","author":"Xu","year":"2022","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.phrs.2024.107280_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/nu11122936","article-title":"Dietary factors in the control of gut homeostasis, intestinal stem cells, and colorectal cancer","volume":"11","author":"Francescangeli","year":"2019","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41580-022-00510-w","article-title":"Ageing and rejuvenation of tissue stem cells and their niches","volume":"24","author":"Brunet","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.phrs.2024.107280_bib38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbrc.2021.03.175","article-title":"YTHDF1-regulated expression of TEAD1 contributes to the maintenance of intestinal stem cells","volume":"557","author":"Jiang","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.phrs.2024.107280_bib39","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1007\/s12035-022-02833-3","article-title":"MSC promotes the secretion of exosomal miR-34a-5p and improve intestinal barrier function through METTL3-mediated Pre-miR-34A m(6)A modification","volume":"59","author":"Li","year":"2022","journal-title":"Mol. Neurobiol."},{"issue":"12","key":"10.1016\/j.phrs.2024.107280_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abl5723","article-title":"m(6)A mRNA modification maintains colonic epithelial cell homeostasis via NF-\u03baB-mediated antiapoptotic pathway","volume":"8","author":"Zhang","year":"2022","journal-title":"Sci. Adv."},{"issue":"4","key":"10.1016\/j.phrs.2024.107280_bib41","doi-asserted-by":"crossref","DOI":"10.1093\/femsre\/fuad036","article-title":"Crosstalk between gut microbiota and RNA N6-methyladenosine modification in cancer","volume":"47","author":"Su","year":"2023","journal-title":"FEMS Microbiol. Rev."},{"issue":"8","key":"10.1016\/j.phrs.2024.107280_bib42","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1136\/gutjnl-2022-328845","article-title":"Targeting m(6)A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer","volume":"72","author":"Bao","year":"2023","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.phrs.2024.107280_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.602","article-title":"Downregulation of microRNA-6125 promotes colorectal cancer growth through YTHDF2-dependent recognition of N6-methyladenosine-modified GSK3\u03b2","volume":"11","author":"Li","year":"2021","journal-title":"Clin. Transl. Med"},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib44","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13046-022-02285-6","article-title":"A reciprocal feedback between N6-methyladenosine reader YTHDF3 and lncRNA DICER1-AS1 promotes glycolysis of pancreatic cancer through inhibiting maturation of miR-5586-5p","volume":"41","author":"Hu","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.phrs.2024.107280_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101308","article-title":"The N6-methyladenosine reader protein YTHDC2 promotes gastric cancer progression via enhancing YAP mRNA translation","volume":"16","author":"Yuan","year":"2022","journal-title":"Transl. Oncol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib46","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/s41467-020-15403-9","article-title":"An oncopeptide regulates m(6)A recognition by the m(6)A reader IGF2BP1 and tumorigenesis","volume":"11","author":"Zhu","year":"2020","journal-title":"Nat. Commun."},{"issue":"13","key":"10.1016\/j.phrs.2024.107280_bib47","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/s41388-022-02189-x","article-title":"LINC01021 maintains tumorigenicity by enhancing N6-methyladenosine reader IMP2 dependent stabilization of MSX1 and JARID2: implication in colorectal cancer","volume":"41","author":"Wu","year":"2022","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib48","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s13045-021-01204-0","article-title":"N6-methyladenosine reader IMP2 stabilizes the ZFAS1\/OLA1 axis and activates the Warburg effect: implication in colorectal cancer","volume":"14","author":"Lu","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib49","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s13046-020-01714-8","article-title":"RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer","volume":"39","author":"Yang","year":"2020","journal-title":"J. Exp. Clin. Cancer Res.\u00a0CR"},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib50","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s13046-022-02466-3","article-title":"CircARID1A binds to IGF2BP3 in gastric cancer and promotes cancer proliferation by forming a circARID1A-IGF2BP3-SLC7A5 RNA-protein ternary complex","volume":"41","author":"Ma","year":"2022","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"issue":"5","key":"10.1016\/j.phrs.2024.107280_bib51","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.phrs.2024.107280_bib52","first-page":"1789","article-title":"N6-methyladenosine methyltransferase METTL3 promotes colorectal cancer cell proliferation through enhancing MYC expression","volume":"12","author":"Xiang","year":"2020","journal-title":"Am. J. Transl. Res."},{"issue":"4","key":"10.1016\/j.phrs.2024.107280_bib53","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/cac2.12281","article-title":"m(6) A-mediated regulation of PBX1-GCH1 axis promotes gastric cancer proliferation and metastasis by elevating tetrahydrobiopterin levels","volume":"42","author":"Liu","year":"2022","journal-title":"Cancer Commun."},{"issue":"9","key":"10.1016\/j.phrs.2024.107280_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23931","article-title":"METTL3-mediated m6A methylation of ASPM drives hepatocellular carcinoma cells growth and metastasis","volume":"35","author":"Wang","year":"2021","journal-title":"J. Clin. Lab Anal."},{"key":"10.1016\/j.phrs.2024.107280_bib55","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbrc.2021.05.048","article-title":"The M6A methyltransferase METTL3 regulates proliferation in esophageal squamous cell carcinoma","volume":"580","author":"Zou","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.phrs.2024.107280_bib56","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41418-021-00879-9","article-title":"lncRNA THAP7-AS1, transcriptionally activated by SP1 and post-transcriptionally stabilized by METTL3-mediated m6A modification, exerts oncogenic properties by improving CUL4B entry into the nucleus","volume":"29","author":"Liu","year":"2022","journal-title":"Cell Death Differ."},{"issue":"4","key":"10.1016\/j.phrs.2024.107280_bib57","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1053\/j.gastro.2020.11.013","article-title":"RNA N(6)-methyladenosine methyltransferase METTL3 facilitates colorectal cancer by activating the m(6)A-GLUT1-mTORC1 Axis and Is a therapeutic target","volume":"160","author":"Chen","year":"2021","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.phrs.2024.107280_bib58","doi-asserted-by":"crossref","first-page":"10023","DOI":"10.1080\/21655979.2021.1994721","article-title":"Mechanism of methyltransferase like 3 in epithelial-mesenchymal transition process, invasion, and metastasis in esophageal cancer","volume":"12","author":"Liang","year":"2021","journal-title":"Bioengineered"},{"issue":"7","key":"10.1016\/j.phrs.2024.107280_bib59","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1136\/gutjnl-2019-319639","article-title":"METTL3-mediated m(6)A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance","volume":"69","author":"Wang","year":"2020","journal-title":"Gut"},{"issue":"21","key":"10.1016\/j.phrs.2024.107280_bib60","doi-asserted-by":"crossref","first-page":"21638","DOI":"10.18632\/aging.103959","article-title":"Analysis of METTL3 and METTL14 in hepatocellular carcinoma","volume":"12","author":"Liu","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.phrs.2024.107280_bib61","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.canlet.2019.04.017","article-title":"Emerging strategies in cancer therapy combining chemotherapy with immunotherapy","volume":"454","author":"Luo","year":"2019","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib62","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1186\/s12935-021-02288-x","article-title":"Stabilization of UCA1 by N6-methyladenosine RNA methylation modification promotes colorectal cancer progression","volume":"21","author":"He","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"16","key":"10.1016\/j.phrs.2024.107280_bib63","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1038\/s41388-021-01753-1","article-title":"METTL3-mediated m(6)A methylation of SPHK2 promotes gastric cancer progression by targeting KLF2","volume":"40","author":"Huo","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2024.107280_bib64","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bbrc.2021.01.085","article-title":"METTL3\/IGF2BP1\/CD47 contributes to the sublethal heat treatment induced mesenchymal transition in HCC","volume":"546","author":"Fan","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib65","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2023.5529","article-title":"m(6)A\u2011mediated LINC02038 inhibits colorectal cancer progression via regulation of the FAM172A\/PI3K\/AKT pathway via competitive binding with miR\u2011552\u20115p","volume":"63","author":"Liu","year":"2023","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib66","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1186\/s13046-019-1408-4","article-title":"Upregulated METTL3 promotes metastasis of colorectal Cancer via miR-1246\/SPRED2\/MAPK signaling pathway","volume":"38","author":"Peng","year":"2019","journal-title":"J. Exp. Clin. Cancer Res.\u00a0CR"},{"issue":"14","key":"10.1016\/j.phrs.2024.107280_bib67","doi-asserted-by":"crossref","first-page":"6602","DOI":"10.1111\/jcmm.16664","article-title":"METTL16 promotes cell proliferation by up-regulating cyclin D1 expression in gastric cancer","volume":"25","author":"Wang","year":"2021","journal-title":"J. Cell. Mol. Med."},{"issue":"16","key":"10.1016\/j.phrs.2024.107280_bib68","doi-asserted-by":"crossref","first-page":"8444","DOI":"10.18632\/aging.204980","article-title":"m(6)A methyltransferase METTL16 mediates immune evasion of colorectal cancer cells via epigenetically regulating PD-L1 expression","volume":"15","author":"Wang","year":"2023","journal-title":"Aging"},{"issue":"8","key":"10.1016\/j.phrs.2024.107280_bib69","article-title":"WTAP activates MAPK signaling through m6A methylation in VEGFA mRNA-mediated by YTHDC1 to promote colorectal cancer development","volume":"37","author":"Ye","year":"2023","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib70","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41419-021-04459-0","article-title":"TCF4 and HuR mediated-METTL14 suppresses dissemination of colorectal cancer via N6-methyladenosine-dependent silencing of ARRDC4","volume":"13","author":"Wang","year":"2021","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.phrs.2024.107280_bib71","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1111\/cas.15011","article-title":"Methyl CpG binding protein 2 promotes colorectal cancer metastasis by regulating N(6) -methyladenosine methylation through methyltransferase-like 14","volume":"112","author":"Wang","year":"2021","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib72","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12943-022-01521-z","article-title":"METTL14-mediated m(6)A modification of circORC5 suppresses gastric cancer progression by regulating miR-30c-2-3p\/AKT1S1 axis","volume":"21","author":"Fan","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib73","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41392-020-00299-0","article-title":"m6A RNA methylation-mediated HNF3\u03b3 reduction renders hepatocellular carcinoma dedifferentiation and sorafenib resistance","volume":"5","author":"Zhou","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib74","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12943-020-01249-8","article-title":"Upregulation of METTL14 mediates the elevation of PERP mRNA N(6) adenosine methylation promoting the growth and metastasis of pancreatic cancer","volume":"19","author":"Wang","year":"2020","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib75","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41419-022-04503-7","article-title":"N6-methyladenosine demethylase FTO promotes growth and metastasis of gastric cancer via m(6)A modification of caveolin-1 and metabolic regulation of mitochondrial dynamics","volume":"13","author":"Zhou","year":"2022","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib76","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s13046-021-02096-1","article-title":"RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma","volume":"40","author":"Cui","year":"2021","journal-title":"J. Exp. Clin. Cancer Res.\u00a0CR"},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib77","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12943-022-01522-y","article-title":"Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification","volume":"21","author":"Hu","year":"2022","journal-title":"Mol. Cancer"},{"issue":"37","key":"10.1016\/j.phrs.2024.107280_bib78","doi-asserted-by":"crossref","first-page":"5600","DOI":"10.1038\/s41388-021-01966-4","article-title":"N(6)-methyladenosine demethylase ALKBH5 suppresses malignancy of esophageal cancer by regulating microRNA biogenesis and RAI1 expression","volume":"40","author":"Chen","year":"2021","journal-title":"Oncogene"},{"issue":"1-2","key":"10.1016\/j.phrs.2024.107280_bib79","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41417-020-0193-8","article-title":"HDAC3-dependent transcriptional repression of FOXA2 regulates FTO\/m6A\/MYC signaling to contribute to the development of gastric cancer","volume":"28","author":"Yang","year":"2021","journal-title":"Cancer Gene Ther."},{"issue":"6","key":"10.1016\/j.phrs.2024.107280_bib80","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1002\/hep.31222","article-title":"SIRT1 Regulates N(6) -methyladenosine RNA modification in hepatocarcinogenesis by inducing RANBP2-dependent FTO SUMOylation","volume":"72","author":"Liu","year":"2020","journal-title":"Hepatol."},{"issue":"3","key":"10.1016\/j.phrs.2024.107280_bib81","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.772","article-title":"FTO promotes colorectal cancer progression and chemotherapy resistance via demethylating G6PD\/PARP1","volume":"12","author":"Wang","year":"2022","journal-title":"Clin. Transl. Med."},{"issue":"3","key":"10.1016\/j.phrs.2024.107280_bib82","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s13105-019-00690-8","article-title":"ALKBH5 promotes invasion and metastasis of gastric cancer by decreasing methylation of the lncRNA NEAT1","volume":"75","author":"Zhang","year":"2019","journal-title":"J. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib83","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1186\/s12885-021-08449-5","article-title":"A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis","volume":"21","author":"Qu","year":"2021","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.phrs.2024.107280_bib84","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1279","article-title":"RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A-YTHDF2-dependent manner","volume":"13","author":"Shen","year":"2023","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib85","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12943-020-01158-w","article-title":"RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner","volume":"19","author":"Guo","year":"2020","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib86","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12943-020-01239-w","article-title":"ALKBH5 suppresses malignancy of hepatocellular carcinoma via m(6)A-guided epigenetic inhibition of LYPD1","volume":"19","author":"Chen","year":"2020","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib87","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab."},{"issue":"11","key":"10.1016\/j.phrs.2024.107280_bib88","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/cac2.12374","article-title":"Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities","volume":"42","author":"Ge","year":"2022","journal-title":"Cancer Commun."},{"issue":"5","key":"10.1016\/j.phrs.2024.107280_bib89","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1002\/jcp.30128","article-title":"HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1\u03b1","volume":"236","author":"Yang","year":"2021","journal-title":"J. Cell. Physiol."},{"issue":"14","key":"10.1016\/j.phrs.2024.107280_bib90","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1158\/0008-5472.CAN-20-4163","article-title":"USP48 Is Upregulated by Mettl14 to Attenuate Hepatocellular Carcinoma via Regulating SIRT6 Stabilization","volume":"81","author":"Du","year":"2021","journal-title":"Cancer Res."},{"issue":"5-6","key":"10.1016\/j.phrs.2024.107280_bib91","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1101\/gad.334516.119","article-title":"PARP and PARG inhibitors in cancer treatment","volume":"34","author":"Slade","year":"2020","journal-title":"Genes Dev."},{"issue":"3","key":"10.1016\/j.phrs.2024.107280_bib92","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00018-022-04129-0","article-title":"METTL3 promotes oxaliplatin resistance of gastric cancer CD133+\u2009stem cells by promoting PARP1 mRNA stability","volume":"79","author":"Li","year":"2022","journal-title":"Cell. Mol. Life Sci. CMLS"},{"issue":"3","key":"10.1016\/j.phrs.2024.107280_bib93","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2022.5396","article-title":"METTL3 antagonizes 5\u2011FU chemotherapy and confers drug resistance in colorectal carcinoma","volume":"61","author":"Li","year":"2022","journal-title":"Int. J. Oncol."},{"issue":"12","key":"10.1016\/j.phrs.2024.107280_bib94","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019103181","article-title":"RNA m(6) A methylation regulates sorafenib resistance in liver cancer through FOXO3-mediated autophagy","volume":"39","author":"Lin","year":"2020","journal-title":"EMBO J."},{"key":"10.1016\/j.phrs.2024.107280_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216122","article-title":"METTL3-m(6)A-EGFR-axis drives lenvatinib resistance in hepatocellular carcinoma","volume":"559","author":"Wang","year":"2023","journal-title":"Cancer Lett."},{"issue":"28","key":"10.1016\/j.phrs.2024.107280_bib96","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202201889","article-title":"APAF1-binding long noncoding RNA promotes tumor growth and multidrug resistance in gastric cancer by blocking apoptosome assembly","volume":"9","author":"Wang","year":"2022","journal-title":"Adv. Sci."},{"issue":"9","key":"10.1016\/j.phrs.2024.107280_bib97","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.545","article-title":"A methyltransferase-like 14\/miR-99a-5p\/tribble 2 positive feedback circuit promotes cancer stem cell persistence and radioresistance via histone deacetylase 2-mediated epigenetic modulation in esophageal squamous cell carcinoma","volume":"11","author":"Liu","year":"2021","journal-title":"Clin. Transl. Med."},{"issue":"6","key":"10.1016\/j.phrs.2024.107280_bib98","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.848","article-title":"YTHDF2 promotes intrahepatic cholangiocarcinoma progression and desensitises cisplatin treatment by increasing CDKN1B mRNA degradation","volume":"12","author":"Huang","year":"2022","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib99","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s13046-023-02792-0","article-title":"m6A eraser FTO impairs gemcitabine resistance in pancreatic cancer through influencing NEDD4 mRNA stability by regulating the PTEN\/PI3K\/AKT pathway","volume":"42","author":"Lin","year":"2023","journal-title":"J. Exp. Clin. Cancer Res.\u00a0CR"},{"issue":"2","key":"10.1016\/j.phrs.2024.107280_bib100","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1615\/CritRevOncog.2019031641","article-title":"Gemcitabine: a review of chemoresistance in pancreatic cancer","volume":"24","author":"Sarvepalli","year":"2019","journal-title":"Crit. Rev. Oncog."},{"issue":"8","key":"10.1016\/j.phrs.2024.107280_bib101","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.7150\/thno.14848","article-title":"Redox regulation of stem-like cells though the CD44v-xCT axis in colorectal cancer: mechanisms and therapeutic implications","volume":"6","author":"Ju","year":"2016","journal-title":"Theranostics"},{"issue":"9","key":"10.1016\/j.phrs.2024.107280_bib102","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.525","article-title":"RNA N(6) -methyladenosine modification in the lethal teamwork of cancer stem cells and the tumor immune microenvironment: current landscape and therapeutic potential","volume":"11","author":"Zhang","year":"2021","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib103","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13046-021-01934-6","article-title":"Sec62 promotes stemness and chemoresistance of human colorectal cancer through activating Wnt\/\u03b2-catenin pathway","volume":"40","author":"Liu","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"7647","key":"10.1016\/j.phrs.2024.107280_bib104","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nature21713","article-title":"A distinct role for Lgr5(+) stem cells in primary and metastatic colon cancer","volume":"543","author":"de Sousa e Melo","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107280_bib105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev-genet-110711-155641","article-title":"Biosynthesis and function of posttranscriptional modifications of transfer RNAs","volume":"46","author":"El Yacoubi","year":"2012","journal-title":"Annu. Rev. Genet."},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib106","doi-asserted-by":"crossref","first-page":"6314","DOI":"10.1038\/s41467-021-26718-6","article-title":"N(1)-methyladenosine methylation in tRNA drives liver tumourigenesis by regulating cholesterol metabolism","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.phrs.2024.107280_bib107","doi-asserted-by":"crossref","first-page":"8403","DOI":"10.1002\/cam4.5561","article-title":"MFAP2, upregulated by m1A methylation, promotes colorectal cancer invasiveness via CLK3","volume":"12","author":"Xue","year":"2023","journal-title":"Cancer Med."},{"issue":"4","key":"10.1016\/j.phrs.2024.107280_bib108","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20210337","article-title":"Genetic characteristics and prognostic implications of m1A regulators in pancreatic cancer","volume":"41","author":"Zheng","year":"2021","journal-title":"Biosci. Rep."},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib109","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1021\/acs.analchem.9b04505","article-title":"YTHDF2 binds to 5-methylcytosine in RNA and modulates the maturation of Ribosomal RNA","volume":"92","author":"Dai","year":"2020","journal-title":"Anal. Chem."},{"issue":"23","key":"10.1016\/j.phrs.2024.107280_bib110","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1016\/j.molcel.2023.11.003","article-title":"SRSF2 plays an unexpected role as reader of m(5)C on mRNA, linking epitranscriptomics to cancer","volume":"83","author":"Ma","year":"2023","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib111","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/imr.12242","article-title":"New themes in the biological functions of 5-methylcytosine and 5-hydroxymethylcytosine","volume":"263","author":"Moen","year":"2015","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib112","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12967-022-03427-2","article-title":"5-methylcytosine RNA methyltransferases and their potential roles in cancer","volume":"20","author":"Li","year":"2022","journal-title":"J. Transl. Med."},{"issue":"Database issue","key":"10.1016\/j.phrs.2024.107280_bib113","doi-asserted-by":"crossref","first-page":"D805","DOI":"10.1093\/nar\/gku1075","article-title":"COSMIC: exploring the world's knowledge of somatic mutations in human cancer","volume":"43","author":"Forbes","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.phrs.2024.107280_bib114","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s10142-023-01098-w","article-title":"A novel scoring model based on RNA modification \"writers\" can predict the prognosis and guide immunotherapy in gastric cancer","volume":"23","author":"Li","year":"2023","journal-title":"Funct. Integr. Genom."},{"issue":"5","key":"10.1016\/j.phrs.2024.107280_bib115","first-page":"1144","article-title":"m(5) C and m(6) A modification of long noncoding NKILA accelerates cholangiocarcinoma progression via the miR-582-3p-YAP1 axis","volume":"42","author":"Zheng","year":"2022","journal-title":"Liver Int.\u00a0Off. J. Int. Assoc. Study Liver"},{"key":"10.1016\/j.phrs.2024.107280_bib116","first-page":"5445","article-title":"Cross-talk of RNA modification \"writers\" describes tumor stemness and microenvironment and guides personalized immunotherapy for gastric cancer","author":"Li","year":"2023","journal-title":"Aging 15(12"},{"issue":"6","key":"10.1016\/j.phrs.2024.107280_bib117","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1007\/s13577-021-00583-3","article-title":"FOXC2-AS1 stabilizes FOXC2 mRNA via association with NSUN2 in gastric cancer cells","volume":"34","author":"Yan","year":"2021","journal-title":"Hum. Cell"},{"issue":"10","key":"10.1016\/j.phrs.2024.107280_bib118","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1017\/S1355838202024019","article-title":"Two proteins that form a complex are required for 7-methylguanosine modification of yeast tRNA","volume":"8","author":"Alexandrov","year":"2002","journal-title":"RNA"},{"issue":"15","key":"10.1016\/j.phrs.2024.107280_bib119","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1016\/j.cell.2023.05.047","article-title":"QKI shuttles internal m(7)G-modified transcripts into stress granules and modulates mRNA metabolism","volume":"186","author":"Zhao","year":"2023","journal-title":"Cell"},{"issue":"22","key":"10.1016\/j.phrs.2024.107280_bib120","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15225454","article-title":"The m(7)G reader NCBP2 promotes pancreatic cancer progression by upregulating MAPK\/ERK signaling","volume":"15","author":"Xie","year":"2023","journal-title":"Cancers"},{"issue":"16","key":"10.1016\/j.phrs.2024.107280_bib121","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1016\/j.molcel.2021.07.003","article-title":"N(7)-Methylguanosine tRNA modification enhances oncogenic mRNA translation and promotes intrahepatic cholangiocarcinoma progression","volume":"81","author":"Dai","year":"2021","journal-title":"Mol. Cell"},{"issue":"12","key":"10.1016\/j.phrs.2024.107280_bib122","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.661","article-title":"METTL1 promotes hepatocarcinogenesis via m(7) G tRNA modification-dependent translation control","volume":"11","author":"Chen","year":"2021","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib123","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1080\/15548627.2022.2077551","article-title":"N(7)-methylguanosine (m(7)G) tRNA modification: a novel autophagy modulator in cancer","volume":"19","author":"Han","year":"2023","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib124","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1158\/0008-5472.CAN-22-0963","article-title":"METTL1-mediated m7G tRNA modification promotes lenvatinib resistance in hepatocellular carcinoma","volume":"83","author":"Huang","year":"2023","journal-title":"Cancer Res."},{"issue":"24","key":"10.1016\/j.phrs.2024.107280_bib125","doi-asserted-by":"crossref","first-page":"12328","DOI":"10.18632\/aging.102575","article-title":"Overexpressed methyltransferase-like 1 (METTL1) increased chemosensitivity of colon cancer cells to cisplatin by regulating miR-149-3p\/S100A4\/p53 axis","volume":"11","author":"Liu","year":"2019","journal-title":"Aging"},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib126","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/10409238.2020.1856768","article-title":"To protect and modify double-stranded RNA - the critical roles of ADARs in development, immunity and oncogenesis","volume":"56","author":"Erdmann","year":"2021","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"2","key":"10.1016\/j.phrs.2024.107280_bib127","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41416-023-02275-1","article-title":"RNA modifications in cancer","volume":"129","author":"Tang","year":"2023","journal-title":"Br. J. Cancer"},{"issue":"12","key":"10.1016\/j.phrs.2024.107280_bib128","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99976","article-title":"AZIN1 RNA editing confers cancer stemness and enhances oncogenic potential in colorectal cancer","volume":"3","author":"Shigeyasu","year":"2018","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.phrs.2024.107280_bib129","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1084\/jem.20132209","article-title":"RNA editing in RHOQ promotes invasion potential in colorectal cancer","volume":"211","author":"Han","year":"2014","journal-title":"J. Exp. Med."},{"issue":"23","key":"10.1016\/j.phrs.2024.107280_bib130","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1703178114","article-title":"RNA editing of SLC22A3 drives early tumor invasion and metastasis in familial esophageal cancer","volume":"114","author":"Fu","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib131","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1186\/s12967-018-1740-z","article-title":"Enhanced AZIN1 RNA editing and overexpression of its regulatory enzyme ADAR1 are important prognostic biomarkers in gastric cancer","volume":"16","author":"Okugawa","year":"2018","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib132","first-page":"148","article-title":"The aberrant expression of ADAR1 promotes resistance to BET inhibitors in pancreatic cancer by stabilizing c-Myc","volume":"10","author":"Sun","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.phrs.2024.107280_bib133","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2018.12.009","article-title":"Activation of AZIN1 RNA editing is a novel mechanism that promotes invasive potential of cancer-associated fibroblasts in colorectal cancer","volume":"444","author":"Takeda","year":"2019","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib134","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1038\/s41467-023-38581-8","article-title":"ADAR1-mediated RNA editing of SCD1 drives drug resistance and self-renewal in gastric cancer","volume":"14","author":"Wong","year":"2023","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.phrs.2024.107280_bib135","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrm.2015.4","article-title":"A-to-I editing of coding and non-coding RNAs by ADARs","volume":"17","author":"Nishikura","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"17","key":"10.1016\/j.phrs.2024.107280_bib136","article-title":"ADAR1 Suppresses interferon signaling in gastric cancer cells by MicroRNA-302a-mediated IRF9\/STAT1 regulation","volume":"21","author":"Jiang","year":"2020","journal-title":"Int.\u00a0J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.phrs.2024.107280_bib137","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s10620-018-5081-9","article-title":"Combinatory RNA-sequencing analyses reveal a dual mode of gene regulation by ADAR1 in gastric cancer","volume":"63","author":"Cho","year":"2018","journal-title":"Dig. Dis. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib138","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s12276-022-00916-8","article-title":"ADAR1-dependent miR-3144-3p editing simultaneously induces MSI2 expression and suppresses SLC38A4 expression in liver cancer","volume":"55","author":"Kim","year":"2023","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib139","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12943-021-01333-7","article-title":"CircNEIL3 regulatory loop promotes pancreatic ductal adenocarcinoma progression via miRNA sponging and A-to-I RNA-editing","volume":"20","author":"Shen","year":"2021","journal-title":"Mol. Cancer"},{"issue":"12","key":"10.1016\/j.phrs.2024.107280_bib140","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.tig.2019.09.004","article-title":"The Editor's I on disease development","volume":"35","author":"Jain","year":"2019","journal-title":"Trends Genet.: TIG"},{"issue":"4","key":"10.1016\/j.phrs.2024.107280_bib141","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.celrep.2018.03.118","article-title":"The secretion of miR-200s by a PKC\u03b6\/ADAR2 signaling axis promotes liver metastasis in colorectal cancer","volume":"23","author":"Shelton","year":"2018","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib142","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0014-5793(02)02305-0","article-title":"Ribosomal RNA pseudouridines and pseudouridine synthases","volume":"514","author":"Ofengand","year":"2002","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib143","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12943-020-01263-w","article-title":"The role of m(6)A, m(5)C and \u03a8 RNA modifications in cancer: novel therapeutic opportunities","volume":"20","author":"Nombela","year":"2021","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.phrs.2024.107280_bib144","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/hep.30039","article-title":"Oxidatively modified protein-disulfide isomerase-associated 3 promotes dyskerin pseudouridine synthase 1-mediated malignancy and survival of hepatocellular carcinoma cells","volume":"68","author":"Ko","year":"2018","journal-title":"Hepatol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib145","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13046-021-01951-5","article-title":"HSP90-dependent PUS7 overexpression facilitates the metastasis of colorectal cancer cells by regulating LASP1 abundance","volume":"40","author":"Song","year":"2021","journal-title":"J. Exp. Clin. Cancer Res.\u00a0CR"},{"issue":"10","key":"10.1016\/j.phrs.2024.107280_bib146","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202004344","article-title":"Dual inhibition of DKC1 and MEK1\/2 synergistically restrains the growth of colorectal cancer cells","volume":"8","author":"Kan","year":"2021","journal-title":"Adv. Sci."},{"issue":"5","key":"10.1016\/j.phrs.2024.107280_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107611","article-title":"Loss of m(1)acp(3)\u03a8 Ribosomal RNA modification is a major feature of cancer","volume":"31","author":"Babaian","year":"2020","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.phrs.2024.107280_bib148","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1784","article-title":"RNA epigenetic modifications in ovarian cancer: the changes, chances, and challenges","volume":"14","author":"Ye","year":"2023","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"10.1016\/j.phrs.2024.107280_bib149","doi-asserted-by":"crossref","first-page":"1031184","DOI":"10.3389\/fimmu.2022.1031184","article-title":"Interplay of four types of RNA modification writers revealed distinct tumor microenvironment and biological characteristics in pancreatic cancer","volume":"13","author":"Gao","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib150","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12943-021-01322-w","article-title":"Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer","volume":"20","author":"Chen","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phrs.2024.107280_bib151","article-title":"YTHDF2 inhibits gastric cancer cell growth by regulating FOXC2 signaling pathway","volume":"11","author":"Shen","year":"2020","journal-title":"Front. Genet."},{"issue":"5","key":"10.1016\/j.phrs.2024.107280_bib152","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.7150\/ijbs.86658","article-title":"The m6A modification-mediated positive feedback between glycolytic lncRNA SLC2A1-DT and c-Myc promotes tumorigenesis of hepatocellular carcinoma","volume":"20","author":"Zeng","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.phrs.2024.107280_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2022.146250","article-title":"Comprehensive analysis of m(6)A regulator-based methylation modification patterns characterized by distinct immune profiles in colon adenocarcinomas","volume":"821","author":"Liu","year":"2022","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib154","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1186\/s12967-023-04578-6","article-title":"ALKBH5 enhances lipid metabolism reprogramming by increasing stability of FABP5 to promote pancreatic neuroendocrine neoplasms progression in an m6A-IGF2BP2-dependent manner","volume":"21","author":"Chen","year":"2023","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib155","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12943-022-01647-0","article-title":"The m(6)A demethylase ALKBH5-mediated upregulation of DDIT4-AS1 maintains pancreatic cancer stemness and suppresses chemosensitivity by activating the mTOR pathway","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phrs.2024.107280_bib156","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.975684","article-title":"An m5C methylation regulator-associated signature predicts prognosis and therapy response in pancreatic cancer","volume":"10","author":"Yun","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.phrs.2024.107280_bib157","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15061800","article-title":"Integrated analysis of N1-methyladenosine methylation regulators-related lncRNAs in hepatocellular carcinoma","volume":"15","author":"Song","year":"2023","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.phrs.2024.107280_bib158","first-page":"2989","article-title":"RNA methylation regulators contribute to poor prognosis of hepatocellular carcinoma associated with the suppression of bile acid metabolism: a multi-omics analysis","volume":"12","author":"Zhang","year":"2022","journal-title":"Am. J. Cancer Res."},{"issue":"2","key":"10.1016\/j.phrs.2024.107280_bib159","doi-asserted-by":"crossref","DOI":"10.1142\/S0219720022500044","article-title":"RNA modification writers influence tumor microenvironment in gastric cancer and prospects of targeted drug therapy","volume":"20","author":"Song","year":"2022","journal-title":"J. Bioinforma. Comput. Biol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib160","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s40168-018-0430-7","article-title":"Seasonal and algal diet-driven patterns of the digestive microbiota of the European abalone Haliotis tuberculata, a generalist marine herbivore","volume":"6","author":"Gobet","year":"2018","journal-title":"Microbiome"},{"issue":"6053","key":"10.1016\/j.phrs.2024.107280_bib161","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1126\/science.1211057","article-title":"Intestinal microbiota promote enteric virus replication and systemic pathogenesis","volume":"334","author":"Kuss","year":"2011","journal-title":"Sci."},{"issue":"2","key":"10.1016\/j.phrs.2024.107280_bib162","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41422-018-0127-2","article-title":"Transcriptome-wide reprogramming of N(6)-methyladenosine modification by the mouse microbiome","volume":"29","author":"Wang","year":"2019","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib163","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s13054-022-04164-0","article-title":"Oropharyngeal and intestinal concentrations of opportunistic pathogens are independently associated with death of SARS-CoV-2 critically ill adults","volume":"26","author":"Patrier","year":"2022","journal-title":"Crit. Care"},{"issue":"2","key":"10.1016\/j.phrs.2024.107280_bib164","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/iub.2438","article-title":"N(6) -methyladenosine modification of circular RNA circ-ARL3 facilitates Hepatitis B virus-associated hepatocellular carcinoma via sponging miR-1305","volume":"73","author":"Rao","year":"2021","journal-title":"IUBMB Life"},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib165","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13046-022-02586-w","article-title":"Helicobacter pylori-induced NAT10 stabilizes MDM2 mRNA via RNA acetylation to facilitate gastric cancer progression","volume":"42","author":"Deng","year":"2023","journal-title":"J. Exp. Clin. Cancer Res.\u00a0CR"},{"key":"10.1016\/j.phrs.2024.107280_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105937","article-title":"RNA methylation and cancer treatment","volume":"174","author":"Yang","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2024.107280_bib167","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.578816","article-title":"IGF2BP2 promotes liver cancer growth through an m6A-FEN1-dependent mechanism","volume":"10","author":"Pu","year":"2020","journal-title":"Front. Oncol."},{"issue":"11","key":"10.1016\/j.phrs.2024.107280_bib168","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1016\/j.ymthe.2023.09.014","article-title":"METTL5-mediated 18S rRNA m(6)A modification promotes oncogenic mRNA translation and intrahepatic cholangiocarcinoma progression","volume":"31","author":"Dai","year":"2023","journal-title":"Mol. Ther.\u00a0J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.phrs.2024.107280_bib169","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.599340","article-title":"m(5)C RNA methylation primarily affects the ErbB and PI3K-Akt signaling pathways in gastrointestinal cancer","volume":"7","author":"Xiang","year":"2020","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib170","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2023.03.207","article-title":"A-to-I RNA-editing: an epigenetic hallmark cannot be ignored in silencing the tumor microenvironment and is promising in predicting immunotherapy response for esophageal squamous cell carcinoma","volume":"165","author":"Wang","year":"2023","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib171","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1936758","article-title":"Integrated analyses of m(1)A regulator-mediated modification patterns in tumor microenvironment-infiltrating immune cells in colon cancer","volume":"10","author":"Gao","year":"2021","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.phrs.2024.107280_bib172","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12943-022-01500-4","article-title":"The role of m6A RNA methylation in cancer metabolism","volume":"21","author":"An","year":"2022","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.phrs.2024.107280_bib173","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.pt.2024.01.006","article-title":"Emerging roles of the epitranscriptome in parasitic protozoan biology and pathogenesis","volume":"40","author":"Guo","year":"2024","journal-title":"Trends Parasitol."},{"issue":"13","key":"10.1016\/j.phrs.2024.107280_bib174","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1158\/0008-5472.CAN-21-4124","article-title":"Anti-HIV drug elvitegravir suppresses cancer metastasis via increased proteasomal degradation of m6A methyltransferase METTL3","volume":"82","author":"Liao","year":"2022","journal-title":"Cancer Res."},{"issue":"21","key":"10.1016\/j.phrs.2024.107280_bib175","doi-asserted-by":"crossref","first-page":"10197","DOI":"10.1111\/jcmm.16957","article-title":"Hypoxia blocks ferroptosis of hepatocellular carcinoma via suppression of METTL14 triggered YTHDF2-dependent silencing of SLC7A11","volume":"25","author":"Fan","year":"2021","journal-title":"J. Cell Mol. Med."},{"issue":"16","key":"10.1016\/j.phrs.2024.107280_bib176","doi-asserted-by":"crossref","first-page":"10920","DOI":"10.1021\/acs.jmedchem.1c02075","article-title":"Rational design and optimization of m(6)A-RNA Demethylase FTO inhibitors as anticancer agents","volume":"65","author":"Huff","year":"2022","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.phrs.2024.107280_bib177","article-title":"m(6) A Reader YTHDF1-targeting engineered small extracellular vesicles for gastric cancer therapy via epigenetic and immune regulation","volume":"35","author":"You","year":"2023","journal-title":"Adv. Mater."},{"issue":"4","key":"10.1016\/j.phrs.2024.107280_bib178","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1053\/j.gastro.2022.06.024","article-title":"METTL3 inhibits antitumor immunity by targeting m(6)A-BHLHE41-CXCL1\/CXCR2 Axis to promote colorectal cancer","volume":"163","author":"Chen","year":"2022","journal-title":"Gastroenterology"},{"issue":"18","key":"10.1016\/j.phrs.2024.107280_bib179","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1158\/0008-5472.CAN-21-0468","article-title":"M(6)A demethylase ALKBH5 regulates PD-L1 expression and tumor immunoenvironment in intrahepatic cholangiocarcinoma","volume":"81","author":"Qiu","year":"2021","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.phrs.2024.107280_bib180","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1136\/gutjnl-2022-327230","article-title":"Targeting tumour-intrinsic N(7)-methylguanosine tRNA modification inhibits MDSC recruitment and improves anti-PD-1 efficacy","volume":"72","author":"Liu","year":"2023","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.phrs.2024.107280_bib181","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/hep.32585","article-title":"Eliminating METTL1-mediated accumulation of PMN-MDSCs prevents hepatocellular carcinoma recurrence after radiofrequency ablation","volume":"77","author":"Zeng","year":"2023","journal-title":"Hepatol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824002251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824002251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T02:21:22Z","timestamp":1724466082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661824002251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":181,"alternative-id":["S1043661824002251"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107280","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RNA epigenetic modifications in digestive tract cancers: Friends or foes","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107280","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107280"}}